Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.76−0.03 (-3.80%)
Close on Nov 13, 2026Market cap $8.98MP/E –Yield –
Radiopharm Theranostics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Radiopharm Theranostics's price to sales ratio was 3.0× on Nov 11, 2026, against 8.7× a year earlier. Over the last 2 years it ranged from 3.0× to 23.6×, with a median of 10.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.0× | −6.9 |
| 2025 | Dec 31, 2025 | 10.0× | −9.4 |
| 2024 | Dec 31, 2024 | 19.3× | – |
See a number that looks wrong?